Marker Therapeutics, Inc. · NASDAQ:MRKR
New Enterprise Associates 16, L.P. reported a 12.60% stake in Marker Therapeutics, Inc. (Schedule 13D/A)
Event Aug 14, 2025 · Filed Aug 18, 2025
New Enterprise Associates 16, L.P. reported a 12.60% stake in Marker Therapeutics, Inc., 1,625,678 shares, with active intent on Aug 14, 2025. Filed Aug 18, 2025 (Schedule 13D/A).
- Stake
- 12.60%
- Shares
- 1,625,678
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 10 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| New Enterprise Associates 16, L.P. | 12.60% | 1,625,678 |
| NEA Partners 16, L.P. | 12.60% | 1,625,678 |
| NEA 16 GP, LLC | 12.60% | 1,625,678 |
| Forest Baskett | 12.60% | 1,625,678 |
| Ali Behbahani | 12.60% | 1,625,678 |
| Carmen Chang | 12.60% | 1,625,678 |
| Anthony A. Florence, Jr. | 12.60% | 1,625,678 |
| Mohamad H. Makhzoumi | 12.60% | 1,625,678 |
| Scott D. Sandell | 12.60% | 1,625,678 |
| Paul Walker | 12.60% | 1,625,678 |
Source
Related
- Marker Therapeutics, Inc.
- New Enterprise Associates 16, L.P.
- Marker Therapeutics, Inc. shareholders
- Schedule 13D/A · New Enterprise Associates 16, L.P. · Nov 17, 2025
- Schedule 13D/A · New Enterprise Associates 16, L.P. · Dec 23, 2024
- Schedule 13G/A · Alyeska Investment Group, L.P. · Nov 14, 2025
- Schedule 13G/A · Blue Owl Capital Holdings LP · May 15, 2025
- Schedule 13G · Blue Owl Capital Holdings LP · Feb 14, 2025
- Schedule 13G · Alyeska Investment Group, L.P. · Feb 14, 2025